Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer
Clinical trial NCT05519059 · COMPLETED
Trial details
- NCT number
- NCT05519059
- Sponsor
- Adlai Nortye Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2022-09-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.